(b)(4).Method: the actual device was received for analysis.A visual inspection was performed and a review of the device history record (dhr) was performed.Results: evaluation and investigation results will be provided once they are completed, as testing is currently in progress.Per the dhr review the lot meet manufacturing specification at release.Conclusion: once the investigation and device analysis are completed a follow-up report will be submitted.Information from this incident has been included in our product complaint trend reporting systems for monitoring, tracking and trending.
|
It was reported that a patient experienced a reaction during infusion.The patient underwent a left rotator cuff repair, and the catheter placement was an interscalene block.The pump was infusing 0.2% ropivacaine filled to 400mls at 6ml/hr.The incident is further described as the patient developed headache, shaking, redness of face, and chills.Infusion was stopped and the symptoms subsided.The pump was not empty at the time of disconnect and available for return.The patient was reported to be in stable condition.Oct-12-2015-additional information received: the infusion was going for several hours, and around 8 pm the symptoms began.The patient took hydrocodone earlier in the day.The symptoms would come and then go away and return again.The pump was discontinued around 11 pm.It took approximately 4 hours for her to return back to her normal state.She states she is feeling fine now.
|